Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience

BACKGROUND: Triple-negative breast cancer is a heterogeneous molecular subtype of BC. Pathological complete response (pCR) is an important surrogate marker for recurrence-free and overall survival. AIM OF STUDY: The aim of this study was to evaluate clinical and pathological factors that are associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivina, Elina, Blumberga, Lubova, Purkalne, Gunta, Irmejs, Arvids
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018905/
https://www.ncbi.nlm.nih.gov/pubmed/36922883
http://dx.doi.org/10.1186/s13053-023-00249-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018905/
https://www.ncbi.nlm.nih.gov/pubmed/36922883
http://dx.doi.org/10.1186/s13053-023-00249-1

Ejemplares similares